• Off-label disease-modifying therapies
  Resource-poor countries do not have the benefit of all the disease-modifying therapies (DMTs) available in the UK, Europe, and elsewhere. Here I discuss some of the alternative treatments for MS that can be used when the choice of licensed DMTs is limited; I also consider some global initiatives that have provided or could provide additional ways to access some essential DMTs.

The links below take you out of the MS-Selfie website to Prof G’s MS-Selfie newsletter and research archive. Edited posts, consistent with the other site content, will replace them as the website develops.